UTP14 Antibody

What is UTP14 and why is it important in ribosomal biogenesis?

UTP14 is a highly-conserved protein found throughout eukaryotes that contains no recognizable domains . It plays a critical role in ribosome biogenesis, particularly in the processing of pre-ribosomal RNA. UTP14 interacts with multiple RNA elements within the Small Subunit (SSU) processome, with its primary binding sites being helix 26 and helix 45/D-site of the pre-18S rRNA .

Importantly, UTP14 recruits and activates the RNA helicase Dhr1, which is necessary for the removal of U3 snoRNA from the pre-rRNA . This removal is essential for proper folding of the central pseudoknot, a key structural feature of the small ribosomal subunit. Dysfunction of UTP14 has been linked to infertility in men and may contribute to scleroderma and ovarian cancer, highlighting its clinical significance .

Research significance:

• Essential component of the 90S pre-ribosome

• Regulates Dhr1 helicase activity through direct protein interaction

• Traverses a large area of the SSU processome

• Binds multiple RNA elements including pre-18S rRNA and U3 snoRNA

• Critical for 18S rRNA synthesis

What applications are supported by UTP14 antibodies?

UTP14 antibodies support several research applications, each requiring specific optimization:

When selecting an antibody for these applications, researchers should consider both the specific application requirements and the cellular localization of UTP14 (nucleus, specifically nucleolus) . The polyclonal antibodies available, such as the UTP14A Rabbit Polyclonal Antibody (CAB5960), show high reactivity with human samples .

How can researchers validate the specificity of UTP14 antibodies?

Validating antibody specificity is crucial for generating reliable results. For UTP14 antibodies, several approaches are recommended:

Positive controls:

Validate UTP14 antibodies using cell lines known to express UTP14, such as:

• MCF7 (breast cancer cell line)

• A-549 (lung adenocarcinoma cell line)

• NCI-H460 (large cell lung cancer line)

• Mouse spleen and thymus tissues

Western blot validation:

• Expected molecular weight: The calculated molecular weight of UTP14A is 88kDa, but it typically runs at approximately 110kDa on SDS-PAGE gels

• This discrepancy likely reflects post-translational modifications

• Include both positive control lysates and negative controls (knockdown samples if available)

Immunostaining pattern:

• UTP14A localizes to the nucleus, specifically the nucleolus

• Proper staining should show nucleolar enrichment

• Co-staining with other nucleolar markers can confirm specificity

What are the key technical considerations when using UTP14 antibodies for immunoprecipitation?

Immunoprecipitation (IP) with UTP14 antibodies presents several technical challenges due to the protein's nucleolar localization and complex interactions:

Nuclear extraction:

• Standard cell lysis buffers may not efficiently extract nucleolar proteins

• Use specialized nuclear extraction buffers with higher salt concentrations

• Consider sonication to disrupt nucleoli and release UTP14-containing complexes

RNA-dependent interactions:

UV crosslinking studies show that UTP14 binds multiple RNA elements in the SSU processome . When studying protein-protein interactions:

• Include RNase treatments in control samples to distinguish direct from RNA-mediated interactions

• Consider UV crosslinking approaches (like CRAC) to capture transient RNA-protein interactions

Complex preservation:

UTP14 forms part of large ribonucleoprotein complexes. To preserve these:

• Use gentle extraction conditions

• Consider formaldehyde crosslinking for capturing transient interactions

• For co-IP of UTP14 with its interaction partners (like Dhr1), optimize buffer conditions to maintain complex integrity

How can researchers study UTP14 RNA binding properties?

The RNA binding properties of UTP14 are critical to its function in ribosome biogenesis. Several methodological approaches have proven effective:

UV Crosslinking and Analysis of cDNA (CRAC):

This technique has successfully identified UTP14 RNA binding sites . The protocol involves:

• UV irradiation to induce covalent crosslinks between UTP14 and neighboring nucleic acids

• Two-step purification: first via protein A tag under native conditions, then via His6 tag under denaturing conditions

• RNase treatment followed by library preparation and sequencing

Key findings from CRAC analysis:

CRAC analysis revealed that UTP14 binds to multiple RNA elements within the SSU processome:

• Primary binding sites: helix 26 and helix 45/D-site of pre-18S rRNA

• Additional sites: helices 18 and 36/37, 5′-ETS sites

• U3 snoRNA (nucleotides ~20-60), overlapping with Dhr1 binding site

• Potential transient interaction with snR30

Alternative approaches:

While yeast three-hybrid analysis failed to detect specific interactions between UTP14 and helix 26 or helix 45 , researchers could consider:

• Electrophoretic mobility shift assays (EMSA)

• RNA pull-down with biotinylated RNA

• RNA immunoprecipitation (RIP)

What is known about UTP14's protein interaction network?

UTP14 forms multiple protein-protein interactions that are critical to its function:

Established interactions:

• Dhr1: UTP14 directly interacts with and activates the RNA helicase Dhr1, which is crucial for U3 snoRNA removal from pre-rRNA

• Utp22: Yeast two-hybrid analysis confirms direct interaction with Utp22, a component of the UTPC subcomplex

• Rps1 (eS1): UTP14 interacts with this r-protein that remains bound to helix 26 in mature 40S ribosomes

Domain-specific interactions:

The N-terminal portion (residues 1-265) of UTP14 is both necessary and sufficient for interaction with Utp22 and Rps1 . Understanding these domain-specific interactions is crucial when designing truncation constructs for experimental studies.

Functional significance:

The interaction between UTP14 and Dhr1 has functional consequences:

• UTP14 stimulates the unwinding activity of Dhr1 in vitro

• Mutations that reduce UTP14-Dhr1 interaction cause accumulation of Dhr1 and U3 in pre-40S particles, mimicking a helicase-inactive Dhr1 mutant

How can researchers investigate the role of UTP14 in cancer?

UTP14 has been implicated in cancer development, making it an important research target:

Expression analysis:

UTP14A antibodies can be used to examine expression levels across various cancer types:

• Western blotting for quantitative analysis

• IHC-P for spatial distribution in tumor tissues

• Several cancer cell lines serve as positive controls (MCF7, A-549, NCI-H460)

Mechanistic studies:

To understand how UTP14 contributes to cancer:

• Examine effects of UTP14 knockdown/overexpression on ribosome biogenesis

• Investigate interactions with cancer-related pathways

• Study its role in regulating protein synthesis in cancer cells

Therapeutic implications:

Research on UTP14 is crucial for understanding its potential as a therapeutic target in cancer research . Antibodies can help validate:

• Target engagement of small molecule inhibitors

• Efficacy of gene silencing approaches

• Changes in UTP14 expression after treatment

What are the challenges in studying UTP14's structural biology?

Understanding the structural biology of UTP14 presents several challenges:

Limited structural resolution:

Recent structures of the SSU processome have only resolved limited regions of UTP14:

• Residues 845-849 contact the A1 site

• Residues 828-834 contact helix V of the 5′-ETS

• Residues 317-408 and 876-896 wrap around helices VII and VIII of the 5′-ETS

Conformational complexity:

Full-length UTP14 likely undergoes conformational changes that affect its interactions:

• The interaction between full-length UTP14 and Rps1 is enhanced by deletion of amino acids 565-899

• This suggests that full-length UTP14 may fold in a way that inhibits certain interactions outside the context of the SSU processome

Dynamic binding:

UTP14 traverses a large area of the SSU processome, with binding sites that are 60-140 Å apart . This suggests a dynamic protein that may:

• Adopt different conformations at different stages of ribosome assembly

• Make transient contacts with various components

• Coordinate activities across the processing complex

What methodological considerations are important when studying UTP14 mutants?

The study of UTP14 mutants provides valuable insights into its function:

Mutant design strategies:

• Target discrete regions for mutation based on known interaction domains

• The N-terminal portion (residues 1-265) mediates interaction with Utp22 and Rps1

• Mutations within specific regions of UTP14 reduce interaction with Dhr1

Functional readouts:

• Accumulation of Dhr1 and U3 in pre-40S particles serves as a readout for reduced UTP14-Dhr1 interaction

• Helicase activity assays can assess the ability of UTP14 mutants to stimulate Dhr1 unwinding activity in vitro

Genetic approaches:

• Genetic interactions between UTP14 and other factors provide functional insights

• Suppressor screens have identified UTP14 mutations that suppress the bud23Δ mutant phenotype

• Yeast two-hybrid assays can assess the impact of mutations on specific protein-protein interactions

How does UTP14 contribute to the processing of pre-rRNA?

UTP14 plays multiple roles in pre-rRNA processing:

U3 snoRNA unwinding:

• UTP14 recruits and activates the RNA helicase Dhr1

• This activation is crucial for unwinding U3 snoRNA from pre-rRNA

• U3 removal is necessary to allow folding of the central pseudoknot, a key feature of the small subunit

RNA binding:

UTP14 binds multiple elements within pre-rRNA:

• Primary binding sites at helix 26 and helix 45/D-site

• The binding to helix 45/D-site positions UTP14 near the future 3′-end of mature 18S rRNA

• This strategic positioning allows UTP14 to coordinate processing events

Exosome recruitment:

Proteomic analysis of SSU particles lacking UTP14 revealed that UTP14 is needed for efficient recruitment of the RNA exosome . This positions UTP14 to potentially communicate the status of SSU processome assembly to both Dhr1 and the exosome .

What are the best practices for western blotting with UTP14 antibodies?

When performing western blotting with UTP14 antibodies, researchers should consider:

Sample preparation:

• Use specialized lysis buffers for efficient nuclear protein extraction

• Include protease inhibitors to prevent degradation

• Consider phosphatase inhibitors if studying UTP14 phosphorylation states

Gel electrophoresis:

• UTP14A has a calculated MW of 88kDa but runs at approximately 110kDa

• Use 8-10% gels for optimal resolution in this molecular weight range

• Include appropriate molecular weight markers

Antibody conditions:

• Recommended dilution range: 1:200 - 1:2000 for western blotting

• Optimize blocking conditions to minimize background

• Validate with positive control samples (MCF7, A-549, NCI-H460, mouse spleen, mouse thymus)

Detection considerations:

• Use ECL detection systems appropriate for the expected signal intensity

• For quantitative analysis, consider fluorescent secondary antibodies

• When analyzing results, be aware of the discrepancy between calculated and observed molecular weights

How can researchers distinguish UTP14A from its retrotransposed copy?

According to the search results, an autosomal retrotransposed copy of the X-linked UTP14A gene exists on chromosome 13 . Researchers should consider:

Primer/probe design:

• Design PCR primers or hybridization probes that target unique sequences

• Focus on regions with sequence divergence between the original gene and its retrotransposed copy

• Consider targeting intron sequences present only in the original gene

Expression analysis:

• Use RT-PCR with gene-specific primers to distinguish between transcripts

• Consider tissue-specific expression patterns

• RNA-seq analysis can distinguish between transcripts with sufficiently divergent sequences

Antibody considerations:

• Standard antibodies may not distinguish between protein products

• Consider raising antibodies against unique epitopes if the proteins have diverged

• Use cellular localization patterns to help distinguish between paralogs

This distinction is particularly important when studying UTP14 in human samples, as the presence of a retrotransposed copy could complicate interpretation of experimental results.